nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Alfentanil—ALB—hematologic cancer	0.000685	0.363	CrCbGaD
Remifentanil—Alfentanil—ABCB1—hematologic cancer	0.000654	0.347	CrCbGaD
Remifentanil—Pethidine—ALB—hematologic cancer	0.000309	0.164	CrCbGaD
Remifentanil—Fentanyl—ABCB1—hematologic cancer	0.000239	0.127	CrCbGaD
Remifentanil—Cardiac disorder—Methotrexate—hematologic cancer	0.000119	0.000142	CcSEcCtD
Remifentanil—Sweating—Doxorubicin—hematologic cancer	0.000119	0.000141	CcSEcCtD
Remifentanil—Rash—Vincristine—hematologic cancer	0.000119	0.000141	CcSEcCtD
Remifentanil—Dermatitis—Vincristine—hematologic cancer	0.000119	0.000141	CcSEcCtD
Remifentanil—Pain—Triamcinolone—hematologic cancer	0.000118	0.000141	CcSEcCtD
Remifentanil—Haematuria—Doxorubicin—hematologic cancer	0.000118	0.000141	CcSEcCtD
Remifentanil—Headache—Vincristine—hematologic cancer	0.000118	0.00014	CcSEcCtD
Remifentanil—Loss of consciousness—Prednisone—hematologic cancer	0.000118	0.00014	CcSEcCtD
Remifentanil—Hypotension—Dexamethasone—hematologic cancer	0.000117	0.00014	CcSEcCtD
Remifentanil—Hypotension—Betamethasone—hematologic cancer	0.000117	0.00014	CcSEcCtD
Remifentanil—Nausea—Carmustine—hematologic cancer	0.000117	0.000139	CcSEcCtD
Remifentanil—Angiopathy—Methotrexate—hematologic cancer	0.000117	0.000139	CcSEcCtD
Remifentanil—Vomiting—Irinotecan—hematologic cancer	0.000117	0.000139	CcSEcCtD
Remifentanil—Vomiting—Mitoxantrone—hematologic cancer	0.000117	0.000139	CcSEcCtD
Remifentanil—Immune system disorder—Methotrexate—hematologic cancer	0.000116	0.000138	CcSEcCtD
Remifentanil—Nausea—Alitretinoin—hematologic cancer	0.000116	0.000138	CcSEcCtD
Remifentanil—Convulsion—Prednisone—hematologic cancer	0.000116	0.000138	CcSEcCtD
Remifentanil—Visual impairment—Epirubicin—hematologic cancer	0.000116	0.000138	CcSEcCtD
Remifentanil—Mediastinal disorder—Methotrexate—hematologic cancer	0.000116	0.000138	CcSEcCtD
Remifentanil—Hypertension—Prednisone—hematologic cancer	0.000116	0.000138	CcSEcCtD
Remifentanil—Rash—Irinotecan—hematologic cancer	0.000116	0.000138	CcSEcCtD
Remifentanil—Rash—Mitoxantrone—hematologic cancer	0.000116	0.000138	CcSEcCtD
Remifentanil—Dermatitis—Mitoxantrone—hematologic cancer	0.000115	0.000137	CcSEcCtD
Remifentanil—Dermatitis—Irinotecan—hematologic cancer	0.000115	0.000137	CcSEcCtD
Remifentanil—Chills—Methotrexate—hematologic cancer	0.000115	0.000137	CcSEcCtD
Remifentanil—Headache—Irinotecan—hematologic cancer	0.000115	0.000137	CcSEcCtD
Remifentanil—Headache—Mitoxantrone—hematologic cancer	0.000115	0.000137	CcSEcCtD
Remifentanil—Nausea—Ifosfamide—hematologic cancer	0.000115	0.000136	CcSEcCtD
Remifentanil—Feeling abnormal—Triamcinolone—hematologic cancer	0.000114	0.000136	CcSEcCtD
Remifentanil—Diarrhoea—Cisplatin—hematologic cancer	0.000114	0.000136	CcSEcCtD
Remifentanil—Anxiety—Prednisone—hematologic cancer	0.000114	0.000135	CcSEcCtD
Remifentanil—Vomiting—Gemcitabine—hematologic cancer	0.000114	0.000135	CcSEcCtD
Remifentanil—Bradycardia—Doxorubicin—hematologic cancer	0.000113	0.000135	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000113	0.000135	CcSEcCtD
Remifentanil—Paraesthesia—Dexamethasone—hematologic cancer	0.000113	0.000134	CcSEcCtD
Remifentanil—Paraesthesia—Betamethasone—hematologic cancer	0.000113	0.000134	CcSEcCtD
Remifentanil—Rash—Gemcitabine—hematologic cancer	0.000113	0.000134	CcSEcCtD
Remifentanil—Dermatitis—Gemcitabine—hematologic cancer	0.000112	0.000134	CcSEcCtD
Remifentanil—Hypersensitivity—Etoposide—hematologic cancer	0.000112	0.000134	CcSEcCtD
Remifentanil—Erythema—Methotrexate—hematologic cancer	0.000112	0.000133	CcSEcCtD
Remifentanil—Haemoglobin—Doxorubicin—hematologic cancer	0.000112	0.000133	CcSEcCtD
Remifentanil—Headache—Gemcitabine—hematologic cancer	0.000112	0.000133	CcSEcCtD
Remifentanil—Nausea—Vincristine—hematologic cancer	0.000112	0.000133	CcSEcCtD
Remifentanil—Cardiac disorder—Epirubicin—hematologic cancer	0.000112	0.000133	CcSEcCtD
Remifentanil—Flushing—Epirubicin—hematologic cancer	0.000112	0.000133	CcSEcCtD
Remifentanil—Haemorrhage—Doxorubicin—hematologic cancer	0.000111	0.000132	CcSEcCtD
Remifentanil—Hypersensitivity—Prednisolone—hematologic cancer	0.000111	0.000132	CcSEcCtD
Remifentanil—Pharyngitis—Doxorubicin—hematologic cancer	0.00011	0.000131	CcSEcCtD
Remifentanil—Dyspepsia—Dexamethasone—hematologic cancer	0.00011	0.000131	CcSEcCtD
Remifentanil—Dyspepsia—Betamethasone—hematologic cancer	0.00011	0.000131	CcSEcCtD
Remifentanil—Urticaria—Triamcinolone—hematologic cancer	0.00011	0.000131	CcSEcCtD
Remifentanil—Body temperature increased—Triamcinolone—hematologic cancer	0.000109	0.00013	CcSEcCtD
Remifentanil—Anaphylactic shock—Prednisone—hematologic cancer	0.000109	0.00013	CcSEcCtD
Remifentanil—Oedema—Prednisone—hematologic cancer	0.000109	0.00013	CcSEcCtD
Remifentanil—Angiopathy—Epirubicin—hematologic cancer	0.000109	0.00013	CcSEcCtD
Remifentanil—Nausea—Mitoxantrone—hematologic cancer	0.000109	0.00013	CcSEcCtD
Remifentanil—Nausea—Irinotecan—hematologic cancer	0.000109	0.00013	CcSEcCtD
Remifentanil—Immune system disorder—Epirubicin—hematologic cancer	0.000109	0.000129	CcSEcCtD
Remifentanil—Mediastinal disorder—Epirubicin—hematologic cancer	0.000108	0.000129	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000108	0.000129	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000108	0.000129	CcSEcCtD
Remifentanil—Chills—Epirubicin—hematologic cancer	0.000108	0.000128	CcSEcCtD
Remifentanil—Pruritus—Etoposide—hematologic cancer	0.000108	0.000128	CcSEcCtD
Remifentanil—Shock—Prednisone—hematologic cancer	0.000107	0.000128	CcSEcCtD
Remifentanil—Arrhythmia—Epirubicin—hematologic cancer	0.000107	0.000128	CcSEcCtD
Remifentanil—Pain—Betamethasone—hematologic cancer	0.000107	0.000128	CcSEcCtD
Remifentanil—Pain—Dexamethasone—hematologic cancer	0.000107	0.000128	CcSEcCtD
Remifentanil—Visual impairment—Doxorubicin—hematologic cancer	0.000107	0.000128	CcSEcCtD
Remifentanil—Nervous system disorder—Prednisone—hematologic cancer	0.000107	0.000128	CcSEcCtD
Remifentanil—Tachycardia—Prednisone—hematologic cancer	0.000107	0.000127	CcSEcCtD
Remifentanil—Skin disorder—Prednisone—hematologic cancer	0.000106	0.000126	CcSEcCtD
Remifentanil—Nausea—Gemcitabine—hematologic cancer	0.000106	0.000126	CcSEcCtD
Remifentanil—Vomiting—Cisplatin—hematologic cancer	0.000106	0.000126	CcSEcCtD
Remifentanil—Hyperhidrosis—Prednisone—hematologic cancer	0.000106	0.000126	CcSEcCtD
Remifentanil—Rash—Cisplatin—hematologic cancer	0.000105	0.000125	CcSEcCtD
Remifentanil—Dermatitis—Cisplatin—hematologic cancer	0.000105	0.000125	CcSEcCtD
Remifentanil—Erythema—Epirubicin—hematologic cancer	0.000105	0.000125	CcSEcCtD
Remifentanil—Diarrhoea—Etoposide—hematologic cancer	0.000104	0.000124	CcSEcCtD
Remifentanil—Anaemia—Methotrexate—hematologic cancer	0.000103	0.000123	CcSEcCtD
Remifentanil—Feeling abnormal—Dexamethasone—hematologic cancer	0.000103	0.000123	CcSEcCtD
Remifentanil—Feeling abnormal—Betamethasone—hematologic cancer	0.000103	0.000123	CcSEcCtD
Remifentanil—Cardiac disorder—Doxorubicin—hematologic cancer	0.000103	0.000123	CcSEcCtD
Remifentanil—Flushing—Doxorubicin—hematologic cancer	0.000103	0.000123	CcSEcCtD
Remifentanil—Hypersensitivity—Triamcinolone—hematologic cancer	0.000102	0.000121	CcSEcCtD
Remifentanil—Angiopathy—Doxorubicin—hematologic cancer	0.000101	0.00012	CcSEcCtD
Remifentanil—Dizziness—Etoposide—hematologic cancer	0.000101	0.00012	CcSEcCtD
Remifentanil—Immune system disorder—Doxorubicin—hematologic cancer	0.000101	0.00012	CcSEcCtD
Remifentanil—Mediastinal disorder—Doxorubicin—hematologic cancer	0.0001	0.000119	CcSEcCtD
Remifentanil—Chills—Doxorubicin—hematologic cancer	9.99e-05	0.000119	CcSEcCtD
Remifentanil—Urticaria—Betamethasone—hematologic cancer	9.97e-05	0.000119	CcSEcCtD
Remifentanil—Urticaria—Dexamethasone—hematologic cancer	9.97e-05	0.000119	CcSEcCtD
Remifentanil—Dizziness—Prednisolone—hematologic cancer	9.94e-05	0.000118	CcSEcCtD
Remifentanil—Arrhythmia—Doxorubicin—hematologic cancer	9.94e-05	0.000118	CcSEcCtD
Remifentanil—Body temperature increased—Dexamethasone—hematologic cancer	9.92e-05	0.000118	CcSEcCtD
Remifentanil—Body temperature increased—Betamethasone—hematologic cancer	9.92e-05	0.000118	CcSEcCtD
Remifentanil—Nausea—Cisplatin—hematologic cancer	9.88e-05	0.000118	CcSEcCtD
Remifentanil—Paraesthesia—Prednisone—hematologic cancer	9.81e-05	0.000117	CcSEcCtD
Remifentanil—Pruritus—Triamcinolone—hematologic cancer	9.78e-05	0.000116	CcSEcCtD
Remifentanil—Cough—Methotrexate—hematologic cancer	9.76e-05	0.000116	CcSEcCtD
Remifentanil—Convulsion—Methotrexate—hematologic cancer	9.69e-05	0.000115	CcSEcCtD
Remifentanil—Vomiting—Etoposide—hematologic cancer	9.69e-05	0.000115	CcSEcCtD
Remifentanil—Erythema—Doxorubicin—hematologic cancer	9.69e-05	0.000115	CcSEcCtD
Remifentanil—Anaemia—Epirubicin—hematologic cancer	9.68e-05	0.000115	CcSEcCtD
Remifentanil—Agitation—Epirubicin—hematologic cancer	9.62e-05	0.000115	CcSEcCtD
Remifentanil—Dyspepsia—Prednisone—hematologic cancer	9.62e-05	0.000114	CcSEcCtD
Remifentanil—Rash—Etoposide—hematologic cancer	9.61e-05	0.000114	CcSEcCtD
Remifentanil—Dermatitis—Etoposide—hematologic cancer	9.6e-05	0.000114	CcSEcCtD
Remifentanil—Headache—Etoposide—hematologic cancer	9.55e-05	0.000114	CcSEcCtD
Remifentanil—Rash—Prednisolone—hematologic cancer	9.48e-05	0.000113	CcSEcCtD
Remifentanil—Dermatitis—Prednisolone—hematologic cancer	9.47e-05	0.000113	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	9.46e-05	0.000113	CcSEcCtD
Remifentanil—Headache—Prednisolone—hematologic cancer	9.42e-05	0.000112	CcSEcCtD
Remifentanil—Syncope—Epirubicin—hematologic cancer	9.39e-05	0.000112	CcSEcCtD
Remifentanil—Constipation—Prednisone—hematologic cancer	9.34e-05	0.000111	CcSEcCtD
Remifentanil—Confusional state—Methotrexate—hematologic cancer	9.21e-05	0.00011	CcSEcCtD
Remifentanil—Loss of consciousness—Epirubicin—hematologic cancer	9.2e-05	0.00011	CcSEcCtD
Remifentanil—Dizziness—Triamcinolone—hematologic cancer	9.14e-05	0.000109	CcSEcCtD
Remifentanil—Cough—Epirubicin—hematologic cancer	9.14e-05	0.000109	CcSEcCtD
Remifentanil—Anaphylactic shock—Methotrexate—hematologic cancer	9.13e-05	0.000109	CcSEcCtD
Remifentanil—Convulsion—Epirubicin—hematologic cancer	9.07e-05	0.000108	CcSEcCtD
Remifentanil—Nausea—Etoposide—hematologic cancer	9.06e-05	0.000108	CcSEcCtD
Remifentanil—Hypertension—Epirubicin—hematologic cancer	9.04e-05	0.000108	CcSEcCtD
Remifentanil—Feeling abnormal—Prednisone—hematologic cancer	9e-05	0.000107	CcSEcCtD
Remifentanil—Nervous system disorder—Methotrexate—hematologic cancer	8.96e-05	0.000107	CcSEcCtD
Remifentanil—Anaemia—Doxorubicin—hematologic cancer	8.95e-05	0.000107	CcSEcCtD
Remifentanil—Thrombocytopenia—Methotrexate—hematologic cancer	8.94e-05	0.000106	CcSEcCtD
Remifentanil—Nausea—Prednisolone—hematologic cancer	8.93e-05	0.000106	CcSEcCtD
Remifentanil—Agitation—Doxorubicin—hematologic cancer	8.9e-05	0.000106	CcSEcCtD
Remifentanil—Anxiety—Epirubicin—hematologic cancer	8.88e-05	0.000106	CcSEcCtD
Remifentanil—Pruritus—Betamethasone—hematologic cancer	8.88e-05	0.000106	CcSEcCtD
Remifentanil—Pruritus—Dexamethasone—hematologic cancer	8.88e-05	0.000106	CcSEcCtD
Remifentanil—Skin disorder—Methotrexate—hematologic cancer	8.87e-05	0.000106	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	8.85e-05	0.000105	CcSEcCtD
Remifentanil—Hyperhidrosis—Methotrexate—hematologic cancer	8.83e-05	0.000105	CcSEcCtD
Remifentanil—Vomiting—Triamcinolone—hematologic cancer	8.79e-05	0.000105	CcSEcCtD
Remifentanil—Rash—Triamcinolone—hematologic cancer	8.72e-05	0.000104	CcSEcCtD
Remifentanil—Dry mouth—Epirubicin—hematologic cancer	8.72e-05	0.000104	CcSEcCtD
Remifentanil—Dermatitis—Triamcinolone—hematologic cancer	8.71e-05	0.000104	CcSEcCtD
Remifentanil—Syncope—Doxorubicin—hematologic cancer	8.69e-05	0.000103	CcSEcCtD
Remifentanil—Urticaria—Prednisone—hematologic cancer	8.68e-05	0.000103	CcSEcCtD
Remifentanil—Headache—Triamcinolone—hematologic cancer	8.66e-05	0.000103	CcSEcCtD
Remifentanil—Body temperature increased—Prednisone—hematologic cancer	8.64e-05	0.000103	CcSEcCtD
Remifentanil—Confusional state—Epirubicin—hematologic cancer	8.62e-05	0.000103	CcSEcCtD
Remifentanil—Diarrhoea—Betamethasone—hematologic cancer	8.58e-05	0.000102	CcSEcCtD
Remifentanil—Diarrhoea—Dexamethasone—hematologic cancer	8.58e-05	0.000102	CcSEcCtD
Remifentanil—Anaphylactic shock—Epirubicin—hematologic cancer	8.55e-05	0.000102	CcSEcCtD
Remifentanil—Oedema—Epirubicin—hematologic cancer	8.55e-05	0.000102	CcSEcCtD
Remifentanil—Hypotension—Methotrexate—hematologic cancer	8.53e-05	0.000102	CcSEcCtD
Remifentanil—Loss of consciousness—Doxorubicin—hematologic cancer	8.52e-05	0.000101	CcSEcCtD
Remifentanil—Cough—Doxorubicin—hematologic cancer	8.45e-05	0.000101	CcSEcCtD
Remifentanil—Shock—Epirubicin—hematologic cancer	8.41e-05	0.0001	CcSEcCtD
Remifentanil—Convulsion—Doxorubicin—hematologic cancer	8.39e-05	9.99e-05	CcSEcCtD
Remifentanil—Nervous system disorder—Epirubicin—hematologic cancer	8.38e-05	9.97e-05	CcSEcCtD
Remifentanil—Thrombocytopenia—Epirubicin—hematologic cancer	8.37e-05	9.96e-05	CcSEcCtD
Remifentanil—Hypertension—Doxorubicin—hematologic cancer	8.36e-05	9.96e-05	CcSEcCtD
Remifentanil—Tachycardia—Epirubicin—hematologic cancer	8.34e-05	9.93e-05	CcSEcCtD
Remifentanil—Skin disorder—Epirubicin—hematologic cancer	8.3e-05	9.88e-05	CcSEcCtD
Remifentanil—Dizziness—Dexamethasone—hematologic cancer	8.3e-05	9.88e-05	CcSEcCtD
Remifentanil—Dizziness—Betamethasone—hematologic cancer	8.3e-05	9.88e-05	CcSEcCtD
Remifentanil—Hyperhidrosis—Epirubicin—hematologic cancer	8.26e-05	9.83e-05	CcSEcCtD
Remifentanil—Anxiety—Doxorubicin—hematologic cancer	8.22e-05	9.78e-05	CcSEcCtD
Remifentanil—Nausea—Triamcinolone—hematologic cancer	8.21e-05	9.78e-05	CcSEcCtD
Remifentanil—Paraesthesia—Methotrexate—hematologic cancer	8.2e-05	9.76e-05	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	8.19e-05	9.75e-05	CcSEcCtD
Remifentanil—Dyspnoea—Methotrexate—hematologic cancer	8.14e-05	9.69e-05	CcSEcCtD
Remifentanil—Somnolence—Methotrexate—hematologic cancer	8.12e-05	9.66e-05	CcSEcCtD
Remifentanil—Dry mouth—Doxorubicin—hematologic cancer	8.07e-05	9.6e-05	CcSEcCtD
Remifentanil—Hypersensitivity—Prednisone—hematologic cancer	8.05e-05	9.58e-05	CcSEcCtD
Remifentanil—Dyspepsia—Methotrexate—hematologic cancer	8.04e-05	9.57e-05	CcSEcCtD
Remifentanil—Hypotension—Epirubicin—hematologic cancer	7.99e-05	9.5e-05	CcSEcCtD
Remifentanil—Vomiting—Dexamethasone—hematologic cancer	7.98e-05	9.5e-05	CcSEcCtD
Remifentanil—Vomiting—Betamethasone—hematologic cancer	7.98e-05	9.5e-05	CcSEcCtD
Remifentanil—Confusional state—Doxorubicin—hematologic cancer	7.97e-05	9.49e-05	CcSEcCtD
Remifentanil—Rash—Dexamethasone—hematologic cancer	7.91e-05	9.42e-05	CcSEcCtD
Remifentanil—Rash—Betamethasone—hematologic cancer	7.91e-05	9.42e-05	CcSEcCtD
Remifentanil—Oedema—Doxorubicin—hematologic cancer	7.91e-05	9.41e-05	CcSEcCtD
Remifentanil—Anaphylactic shock—Doxorubicin—hematologic cancer	7.91e-05	9.41e-05	CcSEcCtD
Remifentanil—Dermatitis—Dexamethasone—hematologic cancer	7.9e-05	9.41e-05	CcSEcCtD
Remifentanil—Dermatitis—Betamethasone—hematologic cancer	7.9e-05	9.41e-05	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Methotrexate—hematologic cancer	7.88e-05	9.38e-05	CcSEcCtD
Remifentanil—Headache—Betamethasone—hematologic cancer	7.86e-05	9.36e-05	CcSEcCtD
Remifentanil—Headache—Dexamethasone—hematologic cancer	7.86e-05	9.36e-05	CcSEcCtD
Remifentanil—Pain—Methotrexate—hematologic cancer	7.81e-05	9.29e-05	CcSEcCtD
Remifentanil—Shock—Doxorubicin—hematologic cancer	7.78e-05	9.26e-05	CcSEcCtD
Remifentanil—Nervous system disorder—Doxorubicin—hematologic cancer	7.75e-05	9.23e-05	CcSEcCtD
Remifentanil—Thrombocytopenia—Doxorubicin—hematologic cancer	7.74e-05	9.21e-05	CcSEcCtD
Remifentanil—Pruritus—Prednisone—hematologic cancer	7.73e-05	9.2e-05	CcSEcCtD
Remifentanil—Tachycardia—Doxorubicin—hematologic cancer	7.72e-05	9.19e-05	CcSEcCtD
Remifentanil—Skin disorder—Doxorubicin—hematologic cancer	7.68e-05	9.14e-05	CcSEcCtD
Remifentanil—Paraesthesia—Epirubicin—hematologic cancer	7.67e-05	9.13e-05	CcSEcCtD
Remifentanil—Hyperhidrosis—Doxorubicin—hematologic cancer	7.64e-05	9.1e-05	CcSEcCtD
Remifentanil—Dyspnoea—Epirubicin—hematologic cancer	7.62e-05	9.07e-05	CcSEcCtD
Remifentanil—Somnolence—Epirubicin—hematologic cancer	7.6e-05	9.04e-05	CcSEcCtD
Remifentanil—Feeling abnormal—Methotrexate—hematologic cancer	7.52e-05	8.96e-05	CcSEcCtD
Remifentanil—Dyspepsia—Epirubicin—hematologic cancer	7.52e-05	8.95e-05	CcSEcCtD
Remifentanil—Diarrhoea—Prednisone—hematologic cancer	7.48e-05	8.9e-05	CcSEcCtD
Remifentanil—Nausea—Dexamethasone—hematologic cancer	7.45e-05	8.87e-05	CcSEcCtD
Remifentanil—Nausea—Betamethasone—hematologic cancer	7.45e-05	8.87e-05	CcSEcCtD
Remifentanil—Hypotension—Doxorubicin—hematologic cancer	7.39e-05	8.79e-05	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Epirubicin—hematologic cancer	7.38e-05	8.78e-05	CcSEcCtD
Remifentanil—Pain—Epirubicin—hematologic cancer	7.31e-05	8.7e-05	CcSEcCtD
Remifentanil—Constipation—Epirubicin—hematologic cancer	7.31e-05	8.7e-05	CcSEcCtD
Remifentanil—Urticaria—Methotrexate—hematologic cancer	7.25e-05	8.63e-05	CcSEcCtD
Remifentanil—Dizziness—Prednisone—hematologic cancer	7.23e-05	8.6e-05	CcSEcCtD
Remifentanil—Body temperature increased—Methotrexate—hematologic cancer	7.22e-05	8.59e-05	CcSEcCtD
Remifentanil—Paraesthesia—Doxorubicin—hematologic cancer	7.1e-05	8.45e-05	CcSEcCtD
Remifentanil—Dyspnoea—Doxorubicin—hematologic cancer	7.05e-05	8.39e-05	CcSEcCtD
Remifentanil—Feeling abnormal—Epirubicin—hematologic cancer	7.04e-05	8.38e-05	CcSEcCtD
Remifentanil—Somnolence—Doxorubicin—hematologic cancer	7.03e-05	8.37e-05	CcSEcCtD
Remifentanil—Dyspepsia—Doxorubicin—hematologic cancer	6.96e-05	8.28e-05	CcSEcCtD
Remifentanil—Vomiting—Prednisone—hematologic cancer	6.95e-05	8.27e-05	CcSEcCtD
Remifentanil—Rash—Prednisone—hematologic cancer	6.89e-05	8.2e-05	CcSEcCtD
Remifentanil—Dermatitis—Prednisone—hematologic cancer	6.88e-05	8.19e-05	CcSEcCtD
Remifentanil—Headache—Prednisone—hematologic cancer	6.84e-05	8.15e-05	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Doxorubicin—hematologic cancer	6.83e-05	8.13e-05	CcSEcCtD
Remifentanil—Urticaria—Epirubicin—hematologic cancer	6.79e-05	8.08e-05	CcSEcCtD
Remifentanil—Pain—Doxorubicin—hematologic cancer	6.76e-05	8.05e-05	CcSEcCtD
Remifentanil—Constipation—Doxorubicin—hematologic cancer	6.76e-05	8.05e-05	CcSEcCtD
Remifentanil—Body temperature increased—Epirubicin—hematologic cancer	6.76e-05	8.04e-05	CcSEcCtD
Remifentanil—Hypersensitivity—Methotrexate—hematologic cancer	6.73e-05	8.01e-05	CcSEcCtD
Remifentanil—Feeling abnormal—Doxorubicin—hematologic cancer	6.52e-05	7.76e-05	CcSEcCtD
Remifentanil—Nausea—Prednisone—hematologic cancer	6.49e-05	7.72e-05	CcSEcCtD
Remifentanil—Pruritus—Methotrexate—hematologic cancer	6.46e-05	7.69e-05	CcSEcCtD
Remifentanil—Hypersensitivity—Epirubicin—hematologic cancer	6.3e-05	7.49e-05	CcSEcCtD
Remifentanil—Urticaria—Doxorubicin—hematologic cancer	6.28e-05	7.48e-05	CcSEcCtD
Remifentanil—Body temperature increased—Doxorubicin—hematologic cancer	6.25e-05	7.44e-05	CcSEcCtD
Remifentanil—Diarrhoea—Methotrexate—hematologic cancer	6.25e-05	7.44e-05	CcSEcCtD
Remifentanil—Pruritus—Epirubicin—hematologic cancer	6.05e-05	7.2e-05	CcSEcCtD
Remifentanil—Dizziness—Methotrexate—hematologic cancer	6.04e-05	7.19e-05	CcSEcCtD
Remifentanil—Diarrhoea—Epirubicin—hematologic cancer	5.85e-05	6.96e-05	CcSEcCtD
Remifentanil—Hypersensitivity—Doxorubicin—hematologic cancer	5.83e-05	6.93e-05	CcSEcCtD
Remifentanil—Vomiting—Methotrexate—hematologic cancer	5.81e-05	6.91e-05	CcSEcCtD
Remifentanil—Rash—Methotrexate—hematologic cancer	5.76e-05	6.85e-05	CcSEcCtD
Remifentanil—Dermatitis—Methotrexate—hematologic cancer	5.75e-05	6.85e-05	CcSEcCtD
Remifentanil—Headache—Methotrexate—hematologic cancer	5.72e-05	6.81e-05	CcSEcCtD
Remifentanil—Dizziness—Epirubicin—hematologic cancer	5.65e-05	6.73e-05	CcSEcCtD
Remifentanil—Pruritus—Doxorubicin—hematologic cancer	5.59e-05	6.66e-05	CcSEcCtD
Remifentanil—Vomiting—Epirubicin—hematologic cancer	5.43e-05	6.47e-05	CcSEcCtD
Remifentanil—Nausea—Methotrexate—hematologic cancer	5.42e-05	6.46e-05	CcSEcCtD
Remifentanil—Diarrhoea—Doxorubicin—hematologic cancer	5.41e-05	6.44e-05	CcSEcCtD
Remifentanil—Rash—Epirubicin—hematologic cancer	5.39e-05	6.41e-05	CcSEcCtD
Remifentanil—Dermatitis—Epirubicin—hematologic cancer	5.38e-05	6.41e-05	CcSEcCtD
Remifentanil—Headache—Epirubicin—hematologic cancer	5.35e-05	6.37e-05	CcSEcCtD
Remifentanil—Dizziness—Doxorubicin—hematologic cancer	5.23e-05	6.22e-05	CcSEcCtD
Remifentanil—Nausea—Epirubicin—hematologic cancer	5.08e-05	6.04e-05	CcSEcCtD
Remifentanil—Vomiting—Doxorubicin—hematologic cancer	5.03e-05	5.98e-05	CcSEcCtD
Remifentanil—Rash—Doxorubicin—hematologic cancer	4.99e-05	5.93e-05	CcSEcCtD
Remifentanil—Dermatitis—Doxorubicin—hematologic cancer	4.98e-05	5.93e-05	CcSEcCtD
Remifentanil—Headache—Doxorubicin—hematologic cancer	4.95e-05	5.9e-05	CcSEcCtD
Remifentanil—Nausea—Doxorubicin—hematologic cancer	4.7e-05	5.59e-05	CcSEcCtD
Remifentanil—OPRD1—Signaling Pathways—FGF1—hematologic cancer	4.6e-05	0.000291	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—JAK2—hematologic cancer	4.55e-05	0.000288	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CXCR4—hematologic cancer	4.54e-05	0.000288	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HDAC2—hematologic cancer	4.54e-05	0.000288	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAP2K1—hematologic cancer	4.53e-05	0.000287	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FOXO1—hematologic cancer	4.53e-05	0.000287	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—IL2—hematologic cancer	4.53e-05	0.000287	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PDGFRB—hematologic cancer	4.52e-05	0.000286	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GRB2—hematologic cancer	4.51e-05	0.000285	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CD—hematologic cancer	4.5e-05	0.000285	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PDGFA—hematologic cancer	4.5e-05	0.000285	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CB—hematologic cancer	4.48e-05	0.000283	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PDGFRA—hematologic cancer	4.45e-05	0.000282	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JAK1—hematologic cancer	4.44e-05	0.000281	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCG—hematologic cancer	4.44e-05	0.000281	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KITLG—hematologic cancer	4.43e-05	0.000281	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CBL—hematologic cancer	4.43e-05	0.00028	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL3—hematologic cancer	4.38e-05	0.000277	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT5A—hematologic cancer	4.33e-05	0.000274	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CG—hematologic cancer	4.33e-05	0.000274	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CB—hematologic cancer	4.32e-05	0.000274	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTPN1—hematologic cancer	4.31e-05	0.000273	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN2B—hematologic cancer	4.3e-05	0.000272	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PTPN11—hematologic cancer	4.25e-05	0.000269	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3R1—hematologic cancer	4.25e-05	0.000269	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RASGRP1—hematologic cancer	4.24e-05	0.000268	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HSP90AA1—hematologic cancer	4.23e-05	0.000267	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SYK—hematologic cancer	4.23e-05	0.000267	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CD—hematologic cancer	4.19e-05	0.000265	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CD86—hematologic cancer	4.16e-05	0.000263	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2RA—hematologic cancer	4.14e-05	0.000262	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—JAK2—hematologic cancer	4.13e-05	0.000262	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CREB1—hematologic cancer	4.12e-05	0.000261	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL2—hematologic cancer	4.11e-05	0.00026	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HES1—hematologic cancer	4.1e-05	0.000259	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TERT—hematologic cancer	4.1e-05	0.000259	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NCOR1—hematologic cancer	4.08e-05	0.000258	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT1—hematologic cancer	4.07e-05	0.000258	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL2—hematologic cancer	4.03e-05	0.000255	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF1—hematologic cancer	4.03e-05	0.000255	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CSF2—hematologic cancer	4.03e-05	0.000255	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6R—hematologic cancer	4.02e-05	0.000254	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PDGFB—hematologic cancer	4e-05	0.000253	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FOXO1—hematologic cancer	3.97e-05	0.000251	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—IL2—hematologic cancer	3.97e-05	0.000251	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PDGFRB—hematologic cancer	3.96e-05	0.000251	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3R1—hematologic cancer	3.96e-05	0.000251	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CB—hematologic cancer	3.93e-05	0.000248	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TSC2—hematologic cancer	3.91e-05	0.000247	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PDGFRA—hematologic cancer	3.9e-05	0.000247	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCG—hematologic cancer	3.89e-05	0.000246	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JAK1—hematologic cancer	3.89e-05	0.000246	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—JAK2—hematologic cancer	3.85e-05	0.000243	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAP2K1—hematologic cancer	3.83e-05	0.000243	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GRB2—hematologic cancer	3.81e-05	0.000241	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CD—hematologic cancer	3.81e-05	0.000241	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDGFA—hematologic cancer	3.8e-05	0.000241	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGFR3—hematologic cancer	3.76e-05	0.000238	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KITLG—hematologic cancer	3.75e-05	0.000237	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK14—hematologic cancer	3.72e-05	0.000236	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT5A—hematologic cancer	3.66e-05	0.000232	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	3.65e-05	0.000231	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ESR1—hematologic cancer	3.65e-05	0.000231	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2RA—hematologic cancer	3.63e-05	0.00023	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN2B—hematologic cancer	3.63e-05	0.00023	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FN1—hematologic cancer	3.61e-05	0.000228	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL2—hematologic cancer	3.6e-05	0.000228	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3R1—hematologic cancer	3.59e-05	0.000228	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TERT—hematologic cancer	3.59e-05	0.000227	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—BAD—hematologic cancer	3.56e-05	0.000226	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NFKBIA—hematologic cancer	3.56e-05	0.000226	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOTCH1—hematologic cancer	3.53e-05	0.000223	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CD86—hematologic cancer	3.51e-05	0.000222	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PDGFB—hematologic cancer	3.51e-05	0.000222	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—JAK2—hematologic cancer	3.49e-05	0.000221	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HES1—hematologic cancer	3.46e-05	0.000219	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CD80—hematologic cancer	3.46e-05	0.000219	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CG—hematologic cancer	3.45e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KIT—hematologic cancer	3.45e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—NRAS—hematologic cancer	3.45e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	3.44e-05	0.000218	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TSC2—hematologic cancer	3.43e-05	0.000217	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF1—hematologic cancer	3.41e-05	0.000216	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CSF2—hematologic cancer	3.41e-05	0.000216	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTPN11—hematologic cancer	3.39e-05	0.000215	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	3.36e-05	0.000212	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	3.35e-05	0.000212	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	3.35e-05	0.000212	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	3.32e-05	0.00021	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—MAPK3—hematologic cancer	3.3e-05	0.000209	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	3.3e-05	0.000209	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGFR3—hematologic cancer	3.3e-05	0.000209	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JAK1—hematologic cancer	3.29e-05	0.000208	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	3.29e-05	0.000208	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CREB1—hematologic cancer	3.28e-05	0.000208	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK14—hematologic cancer	3.26e-05	0.000207	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—BRAF—hematologic cancer	3.24e-05	0.000205	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL2—hematologic cancer	3.21e-05	0.000203	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6R—hematologic cancer	3.2e-05	0.000203	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ESR1—hematologic cancer	3.2e-05	0.000203	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CREBBP—hematologic cancer	3.2e-05	0.000203	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FN1—hematologic cancer	3.16e-05	0.0002	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NFKBIA—hematologic cancer	3.12e-05	0.000198	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BAD—hematologic cancer	3.12e-05	0.000198	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOTCH1—hematologic cancer	3.09e-05	0.000196	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	3.07e-05	0.000194	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAP2K1—hematologic cancer	3.05e-05	0.000193	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL2—hematologic cancer	3.05e-05	0.000193	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TERT—hematologic cancer	3.04e-05	0.000192	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CD—hematologic cancer	3.03e-05	0.000192	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CD80—hematologic cancer	3.03e-05	0.000192	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CG—hematologic cancer	3.03e-05	0.000192	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KIT—hematologic cancer	3.03e-05	0.000192	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—NRAS—hematologic cancer	3.03e-05	0.000192	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CA—hematologic cancer	3e-05	0.00019	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTPN11—hematologic cancer	2.97e-05	0.000188	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—KRAS—hematologic cancer	2.97e-05	0.000188	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	2.96e-05	0.000188	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FGF2—hematologic cancer	2.9e-05	0.000184	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—MAPK3—hematologic cancer	2.9e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TSC2—hematologic cancer	2.9e-05	0.000183	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CREB1—hematologic cancer	2.88e-05	0.000182	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3R1—hematologic cancer	2.86e-05	0.000181	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BRAF—hematologic cancer	2.84e-05	0.00018	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL2—hematologic cancer	2.82e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6R—hematologic cancer	2.81e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	2.81e-05	0.000178	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	2.79e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JAK2—hematologic cancer	2.78e-05	0.000176	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	2.76e-05	0.000175	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	2.73e-05	0.000173	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MDM2—hematologic cancer	2.72e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ESR1—hematologic cancer	2.71e-05	0.000171	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	2.68e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FN1—hematologic cancer	2.67e-05	0.000169	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	2.66e-05	0.000168	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	2.64e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MTOR—hematologic cancer	2.64e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	2.64e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BAD—hematologic cancer	2.64e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.63e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	2.62e-05	0.000166	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	2.6e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CD80—hematologic cancer	2.56e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	2.56e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KIT—hematologic cancer	2.56e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	2.56e-05	0.000162	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FGF2—hematologic cancer	2.55e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	2.52e-05	0.00016	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	2.51e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	2.51e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	2.48e-05	0.000157	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	2.45e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	2.45e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JAK2—hematologic cancer	2.44e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CREB1—hematologic cancer	2.43e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CASP3—hematologic cancer	2.43e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL2—hematologic cancer	2.43e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—hematologic cancer	2.42e-05	0.000153	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BRAF—hematologic cancer	2.4e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	2.39e-05	0.000151	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MDM2—hematologic cancer	2.38e-05	0.000151	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL2—hematologic cancer	2.38e-05	0.000151	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6R—hematologic cancer	2.37e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	2.37e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCND1—hematologic cancer	2.37e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—JUN—hematologic cancer	2.36e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MTOR—hematologic cancer	2.32e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	2.32e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	2.29e-05	0.000145	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PTEN—hematologic cancer	2.28e-05	0.000145	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	2.26e-05	0.000143	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	2.25e-05	0.000142	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	2.24e-05	0.000142	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	2.23e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.23e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	2.21e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	2.2e-05	0.000139	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—EP300—hematologic cancer	2.18e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	2.18e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FGF2—hematologic cancer	2.15e-05	0.000136	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	2.15e-05	0.000136	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CASP3—hematologic cancer	2.13e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL2—hematologic cancer	2.13e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	2.12e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SRC—hematologic cancer	2.12e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—hematologic cancer	2.12e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCND1—hematologic cancer	2.08e-05	0.000131	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—JUN—hematologic cancer	2.07e-05	0.000131	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	2.06e-05	0.000131	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JAK2—hematologic cancer	2.06e-05	0.000131	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—hematologic cancer	2.04e-05	0.000129	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NRAS—hematologic cancer	2.04e-05	0.000129	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	2.02e-05	0.000128	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MDM2—hematologic cancer	2.01e-05	0.000128	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	2.01e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTEN—hematologic cancer	2e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	1.96e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	1.96e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MTOR—hematologic cancer	1.96e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	1.95e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	1.95e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—EP300—hematologic cancer	1.91e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MYC—hematologic cancer	1.9e-05	0.00012	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	1.89e-05	0.00012	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	1.87e-05	0.000118	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SRC—hematologic cancer	1.86e-05	0.000118	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	1.84e-05	0.000116	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	1.82e-05	0.000115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	1.81e-05	0.000115	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CASP3—hematologic cancer	1.8e-05	0.000114	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL2—hematologic cancer	1.8e-05	0.000114	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—hematologic cancer	1.79e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—hematologic cancer	1.79e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NRAS—hematologic cancer	1.79e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—KRAS—hematologic cancer	1.75e-05	0.000111	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCND1—hematologic cancer	1.75e-05	0.000111	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—JUN—hematologic cancer	1.75e-05	0.000111	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	1.71e-05	0.000108	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	1.7e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTEN—hematologic cancer	1.69e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MYC—hematologic cancer	1.67e-05	0.000105	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	1.66e-05	0.000105	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	1.66e-05	0.000105	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	1.65e-05	0.000105	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—EP300—hematologic cancer	1.61e-05	0.000102	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	1.61e-05	0.000102	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SRC—hematologic cancer	1.57e-05	9.94e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TP53—hematologic cancer	1.56e-05	9.87e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—KRAS—hematologic cancer	1.54e-05	9.74e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	1.53e-05	9.68e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—hematologic cancer	1.51e-05	9.59e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NRAS—hematologic cancer	1.51e-05	9.56e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HRAS—hematologic cancer	1.49e-05	9.44e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	1.45e-05	9.16e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—hematologic cancer	1.43e-05	9.04e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	1.41e-05	8.95e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MYC—hematologic cancer	1.41e-05	8.91e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	1.4e-05	8.89e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TP53—hematologic cancer	1.37e-05	8.66e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—hematologic cancer	1.32e-05	8.34e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HRAS—hematologic cancer	1.31e-05	8.28e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—KRAS—hematologic cancer	1.3e-05	8.23e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—hematologic cancer	1.25e-05	7.92e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.19e-05	7.56e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TP53—hematologic cancer	1.16e-05	7.32e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—hematologic cancer	1.15e-05	7.31e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HRAS—hematologic cancer	1.11e-05	7e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—hematologic cancer	1.06e-05	6.7e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—hematologic cancer	9.76e-06	6.18e-05	CbGpPWpGaD
